Black Friday: 20% off all orders with code BLACK20.

Palm Beach Vitality

← Back to research

Hormonal

CJC-1295

GHRH Analog — with DAC and No DAC

The catalog and checkout are on this site. Free shipping on orders over $250. BLACK20 is 20% off. Research use only.

Amino acid sequence

N-terminus →

01YTyr
02AAla
03DAsp
04AAla
05IIle
06FPhe
07TThr
08QGln
09SSer
10YTyr
11RArg
12KLys
13VVal
14LLeu
15AAla
16QGln
17LLeu
18SSer
19AAla
20RArg
21KLys
22LLeu
23LLeu
24QGln
25DAsp
26IIle
27LLeu
28SSer
29RArg
→ C
  • Polar
  • Hydrophobic
  • Acidic
  • Basic
  • Linear
  • 29 residues

Scientific Overview

CJC-1295 No DAC (Modified GRF 1-29) is a 29-amino-acid analog of GHRH(1-29) with four amino acid substitutions; CJC-1295 with DAC adds a 30th residue, a lysine carrying a maleimidopropionyl group designed to bind serum albumin. Published CJC-1295 pharmacology almost always studies the DAC (albumin-binding) form. No DAC material is the tetrasubstituted backbone without that lysine–MPA extension. This page covers both research materials. With-DAC formats are listed first because they are the primary catalog offering.

Mechanism focus

Both forms are studied as GHRH-receptor agonists built on a tetrasubstituted GRF(1-29) backbone. With DAC, the maleimidopropionyl lysine is designed to bind serum albumin and extend exposure, which is what human pharmacokinetic papers measured. No DAC lacks that albumin-binding residue, so exposure kinetics differ even though the receptor-facing sequence is related.

Research Use Cases

  • Long-acting GHRH pharmacology (with DAC)
  • Short-acting Modified GRF 1-29 / No DAC comparisons
  • GH/IGF-1 axis kinetics
  • Serum proteome response to sustained GH drive

Use-Case Study Notations

  • Case-study notation: Jetté et al. identified CJC-1295 (tetrasubstituted hGRF 1-29 + maleimido lysine) as a long-lasting albumin-binding GRF analog.
  • Case-study notation: human pharmacology papers on CJC-1295 describe the DAC molecule — multi-day GH and IGF-1 elevation — and are not studies of No DAC alone.
  • PubMed has no confirmed peer-reviewed study of plain tetrasubstituted Mod GRF 1-29 as a standalone compound; document DAC vs No DAC clearly in lab notes.

Selected Studies

  1. 01 hGRF(1-29)-albumin bioconjugates: the identification of CJC-1295 as a long-lasting GRF analogPubMed 15817669
  2. 02 Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting GH releasing hormone analog, in healthy adultsPubMed 16352683
  3. 03 Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analogPubMed 17018654
  4. 04 Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjectsPubMed 19386527

Research Use Only. This page is educational and intended for laboratory research context. Products are not for human consumption and are not intended to diagnose, treat, cure, or prevent any disease.

Request pricingView productsAll products